Evidence map›Paper›PMID 34830071›Full record

ArticleInternational journal of molecular sciences2021

Hong-Bo Fan, Yuan Zou, Qing Han, Qian-Wang Zheng, Ying-Li Liu, Li-Qiong Guo, Jun-Fang Lin

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Immunomodulatory effects ofBiotechnology notes (Amsterdam, Netherlands) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Hong-Bo FanDepartment of Bioengineering, College of Food Science, South China Agricultural University, 483 Wushan Road, Guangzhou 510640, China.
Yuan ZouDepartment of Bioengineering, College of Food Science, South China Agricultural University, 483 Wushan Road, Guangzhou 510640, China.
Qing HanCollege of Marine Science, South China Agricultural University, 483 Wushan Road, Guangzhou 510640, China.
Qian-Wang ZhengDepartment of Bioengineering, College of Food Science, South China Agricultural University, 483 Wushan Road, Guangzhou 510640, China.
Ying-Li LiuBeijing Advanced Innovation Center for Food Nutrition and Human Health, Beijing Technology and Business University, Beijing 100048, China.
Li-Qiong GuoDepartment of Bioengineering, College of Food Science, South China Agricultural University, 483 Wushan Road, Guangzhou 510640, China.
Jun-Fang LinDepartment of Bioengineering, College of Food Science, South China Agricultural University, 483 Wushan Road, Guangzhou 510640, China.ORCID 0000-0002-2981-5188
South China Agricultural University · CNBeijing Technology and Business University · CN

Funding

National Natural Science Foundation of China 31572178National Natural Science Foundation of China 31601564National Natural Science Foundation of China 31772373State Key Research and Development Plan 2017YFD0400204-03State Key Research and Development Plan 2018YED0401200
6 · The paper itself

Abstract

Enhancing the phagocytosis of immune cells with medicines provides benefits to the physiological balance by removing foreign pathogens and apoptotic cells. The fungal immunomodulatory protein (FIP) possessing various immunopotentiation functions may be a good candidate for such drugs. However, the effect and mechanism of FIP on the phagocytic activity is limitedly investigated. Therefore, the present study determined effects of

Indexed as

MacrophagesAnimalsCandida albicansCordycepsEscherichia coliFungal ProteinsImmunologic FactorsMiceNF-kappa BPhagocytosisRAW 264.7 CellsSignal TransductionToll-Like Receptor 4Fungal ProteinsImmunologic FactorsNF-kappa BTlr4 protein, mouseToll-Like Receptor 4Cordyceps militarisimmunityimmunomodulatory proteinmacrophagephagocytosis

Identifiers

PMID34830071
PMCPMC8624516
OpenAlexW3214579660

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.